Annuncio • Mar 17
Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026 Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea Annuncio • Mar 18
Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025 Cosnine Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 27, hagunsandan 2-ro, yangchon-eup, gyeonggi-do, gimpo South Korea Annuncio • Aug 01
Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm On July 31, 2023, Cosnine Co., Ltd. closed the transaction. Board Change • Mar 13
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Apr 08
Full year 2021 earnings released: ₩242 loss per share (vs ₩443 loss in FY 2020) Full year 2021 results: ₩242 loss per share (up from ₩443 loss in FY 2020). Revenue: ₩12.5b (down 40% from FY 2020). Net loss: ₩9.56b (loss narrowed 7.2% from FY 2020). Over the last 3 years on average, earnings per share has increased by 127% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 17
Third quarter 2021 earnings released: ₩9.61 loss per share (vs ₩39.00 loss in 3Q 2020) The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₩2.75b (down 16% from 3Q 2020). Net loss: ₩392.5m (loss narrowed 54% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings. Annuncio • Feb 26
Cosnine Co., Ltd. announced that it has received KRW 6.0116 billion in funding from Icure Pharmaceutical Incorporation On February 25, 2021, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction. Annuncio • Feb 11
Cosnine Co., Ltd. announced that it expects to receive KRW 6.0116 billion in funding Cosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 4,520,000 common share at an issue price of KRW 1,330 per share for gross proceeds of KRW 6,011,600,000 on February 10, 2021. The face value of the shares to be issued is KRW 500 per share. The company will raise funds through third party allocation method. The shares to be issued will have a hold period of one year, post the closing. The payment date is on February 25, 2021. The transaction has been approved by the board of directors of the company. Is New 90 Day High Low • Jan 18
New 90-day low: ₩1,460 The company is down 11% from its price of ₩1,640 on 20 October 2020. The South Korean market is up 30% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 45% over the same period. Annuncio • Dec 04
Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Icure Pharmaceutical Incorporation On December 3, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction. Annuncio • Nov 05
Cosnine Co., Ltd. announced that it expects to receive KRW 4 billion in funding from Icure Pharmaceutical Incorporation and another investor Cosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 20 unregistered coupon non-guaranteed private convertible bonds for gross proceeds of KRW 4,000,000,000 on November 03, 2020. The transaction will include participation from Icure Pharmaceutical Incorporation (KOSDAQ:A175250) and Trevia Inc. for KRW 2,000,000,000. The bonds do not carry any coupon and yield to maturity of 4% and will mature on November 30, 2023. The bonds are 100% convertible into 2,461,538 common shares representing 8.70% of the total number of shares of the company at a conversion price of KRW 1,625 per share. The conversion period of the bonds will start on November 30, 2021 and ends on October 30, 2023. The subscription date and the payment date are on November 3, 2020 and November 30, 2020. The transaction has been approved by the board of directors of the company. Annuncio • Sep 30
Cosnine Co., Ltd. announced that it has received KRW 4.99954 billion in funding On September 29, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction. Annuncio • Sep 26
Cosnine Co., Ltd. announced that it expects to receive KRW 999.99879 million in funding Cosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 709,219 common shares at a price of KRW 1,410 per share for the gross proceeds of KRW 999,998,790 on September 25, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on October 8, 2020. Is New 90 Day High Low • Sep 22
New 90-day high: ₩1,630 The company is up 17% from its price of ₩1,395 on 24 June 2020. The South Korean market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 14% over the same period. Annuncio • Sep 22
Cosnine Co., Ltd. announced that it expects to receive KRW 4.99954 billion in funding Cosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of 3,731,000 common shares at a price of KRW 1,340 per share for the gross proceeds of KRW 4,999,540,000 on September 21, 2020. The transaction will include participation from Bioline Value Investment Fund. The shares issued in the transaction have a par value of KRW 500 per share. The security will be issued at premium of 10%. The transaction will take place through third party allotment. The securities are subject to a hold period of 1 year. The transaction was approved by the board of directors of the company. The transaction is expected to close on September 29, 2020. Annuncio • Sep 11
Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million. Cosnine Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 999.99985 million.
Security Name: Common Stock
Security Type: Common Stock
Securities Offered: 778,210
Price\Range: KRW 1285
Transaction Features: Subsequent Direct Listing Annuncio • Aug 15
Cosnine Co., Ltd. announced that it expects to receive KRW 2 billion in funding from Sangsangin Savings Bank, Investment Arm Cosnine Co., Ltd. (KOSDAQ:A082660) announced a private placement of series 19 registered non-guaranteed private convertible bonds for gross proceeds of KRW 2,000,000,000 on August 14, 2020. The bonds carry a coupon rate of 5% and interest rate to maturity of 7% and will mature on August 18, 2023. The bonds are 100% convertible into 1,594,896 common shares representing 7.45% of the total number of shares of the company at a conversion price of KRW 1,254 per share. The conversion period of the bonds will start on August 18, 2021 and ends on July 18, 2023. The transaction will include participation from returning investor Sangsangin Savings Bank, Investment Arm. The transaction has been approved by the board of directors of the company. The subscription date of the transaction is on the same day and the payment date is on August 18, 2020.